$DMAC 3 SEC Filings

Filed On	Filing
03 Nov 2025	Form 3: Krop Julie, Chief Marketing Officer No securities owned
24 Feb 2025	Form 3: O'Connor Daniel J., Director No securities owned
23 Jan 2024	Form 3: Lorianne Masuoka K., Chief Medical Officer No securities owned
27 Jun 2023	Form 3: Stahlberg Jan, 10% owner and 1 other Holds 4,021,608 shares of Common Shares
23 Jun 2023	Form 3: Jacinto Richard Ii, 10% owner Holds 4,558,823 shares of Voting Common Shares, no par value per share
30 May 2023	Form 3: Kuntz Richard, Director No securities owned
11 Apr 2023	Form 3: Wambeke David J., Chief Business Officer No securities owned
06 Mar 2023	Form 3: Lewis Tanya, Director Holds 0 shares of Voting Common Shares, no par value per share
15 Sep 2022	Form 3: Daves Julie VanOrsdel, SVP Clinical Development Oper. Holds 0 shares of Voting Common Shares, no par value per share
21 Jul 2022	Form 3: Von Koch Thomas, 10% owner and 1 other Holds 2,647,873 shares of Common Shares
02 Feb 2022	Form 3: Cundari Dominic R, Chief Commercial Officer Holds 2,800 shares of Voting Common Shares, no par value per share
05 Jan 2022	Form 3: Gruis Kirsten L, Chief Medical Officer No securities owned
16 Jul 2021	Form 3: Burroughs Amy L., Director No securities owned
16 Jul 2021	Form 3: Semba Charles Pauling, Director No securities owned
05 Nov 2019	Form 3: Gilman Sydney A., VP, Regulatory Affairs No securities owned
06 Dec 2018	Form 3: Alcorn Harry W Jr, Chief Medical Officer Holds 0 shares of Voting Common Shares, no par value per share
06 Dec 2018	Form 3: Verdoorn Todd A., Chief Scientific Officer Holds 1,000 shares of Voting Common Shares, no par value per share
06 Dec 2018	Form 3: Pauls Dietrich John, Director Holds 24,804 shares of Voting Common Shares, no par value per share
06 Dec 2018	Form 3: Kellen Scott, CFO and Secretary Holds 2,040 shares of Voting Common Shares, no par value per share
06 Dec 2018	Form 3: Pilnik Richard D., Director Holds 17,588 shares of Voting Common Shares, no par value per share

Comments